Evidence map›Paper›PMID 25222893›Full record

Trial reportInfection control and hospital epidemiology2014

Does chlorhexidine bathing in adult intensive care units reduce blood culture contamination? A pragmatic cluster-randomized trial.

Edward J Septimus, Mary K Hayden, Ken Kleinman, Taliser R Avery, Julia Moody, Robert A Weinstein, Jason Hickok, Julie Lankiewicz, Adrijana Gombosev, Katherine Haffenreffer and 5 more

Open access · bronzeAbstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Infection control and hospital epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Chlorhexidine gluconate bathing of adult patients in intensive care units in São Paulo, Brazil: Impact on the incidence of healthcare-associated infection.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Edward J SeptimusHospital Corporation of America, Nashville, Tennessee.
Mary K Hayden
Ken Kleinman
Taliser R Avery
Julia Moody
Robert A Weinstein
Jason Hickok
Julie Lankiewicz
Adrijana Gombosev
Katherine Haffenreffer
Rebecca E Kaganov
John A Jernigan
Jonathan B Perlin
Richard Platt
Susan S Huang
Harvard Pilgrim Health Care · USHCA Healthcare · USHarvard University · USUniversity of California, Irvine · USAgency for Healthcare Research and Quality · USCook County Health and Hospitals System · USRush University Medical Center · USTexas A&M Health Science Center · US

Funding

Eastern Massachusetts Prevention Epicenters Program IIU01CI000344 · CI · HARVARD PILGRIM HEALTH CARE, INC. · PI PLATT, RICHARD · 2006 to 2010
$1.8M
NCPDCID CDC HHS 1U01 CI000344NCPDCID CDC HHS U01 CI000344
6 · The paper itself

Abstract

objectiveTo determine rates of blood culture contamination comparing 3 strategies to prevent intensive care unit (ICU) infections: screening and isolation, targeted decolonization, and universal decolonization.

designPragmatic cluster-randomized trial.

settingForty-three hospitals with 74 ICUs; 42 of 43 were community hospitals. PATIENTS: Patients admitted to adult ICUs from July 1, 2009, to September 30, 2011.

methodsAfter a 6-month baseline period, hospitals were randomly assigned to 1 of 3 strategies, with all participating adult ICUs in a given hospital assigned to the same strategy. Arm 1 implemented methicillin-resistant Staphylococcus aureus (MRSA) nares screening and isolation, arm 2 targeted decolonization (screening, isolation, and decolonization of MRSA carriers), and arm 3 conducted no screening but universal decolonization of all patients with mupirocin and chlorhexidine (CHG) bathing. Blood culture contamination rates in the intervention period were compared to the baseline period across all 3 arms.

resultsDuring the 6-month baseline period, 7,926 blood cultures were collected from 3,399 unique patients: 1,099 sets in arm 1, 928 in arm 2, and 1,372 in arm 3. During the 18-month intervention period, 22,761 blood cultures were collected from 9,878 unique patients: 3,055 sets in arm 1, 3,213 in arm 2, and 3,610 in arm 3. Among all individual draws, for arms 1, 2, and 3, the contamination rates were 4.1%, 3.9%, and 3.8% for the baseline period and 3.3%, 3.2%, and 2.4% for the intervention period, respectively. When we evaluated sets of blood cultures rather than individual draws, the contamination rate in arm 1 (screening and isolation) was 9.8% (N = 108 sets) in the baseline period and 7.5% (N = 228) in the intervention period. For arm 2 (targeted decolonization), the baseline rate was 8.4% (N = 78) compared to 7.5% (N = 241) in the intervention period. Arm 3 (universal decolonization) had the greatest decrease in contamination rate, with a decrease from 8.7% (N = 119) contaminated blood cultures during the baseline period to 5.1% (N = 184) during the intervention period. Logistic regression models demonstrated a significant difference across the arms when comparing the reduction in contamination between baseline and intervention periods in both unadjusted (P = .02) and adjusted (P = .02) analyses. Arm 3 resulted in the greatest reduction in blood culture contamination rates, with an unadjusted odds ratio (OR) of 0.56 (95% confidence interval [CI], 0.044-0.71) and an adjusted OR of 0.55 (95% CI, 0.43-0.71).

conclusionIn this large cluster-randomized trial, we demonstrated that universal decolonization with CHG bathing resulted in a significant reduction in blood culture contamination.

Indexed as

AgedBathsChlorhexidineCross InfectionDisinfectantsFemaleHumansIntensive Care UnitsMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedNasal CavitySepsisStaphylococcal InfectionsChlorhexidineDisinfectants

Identifiers

PMID25222893
PMCPMC10860380
OpenAlexW1998051571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.